GA101 P329GLALA, a variant of obinutuzumab with abolished ADCC, ADCP and CDC function but retained cell death induction, is as efficient as rituximab in B-cell depletion and antitumor activity

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Herter, Sylvia, Herting, Frank, Muth, Gunter, van Puijenbroek, Erwin, Schlothauer, Tilman, Ferrara, Claudia, Brady, Kevin, Lang, Sabine, Bacac, Marina, Mössner, Ekkehard, Umana, Pablo, Klein, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2018
Assuntos:
Online Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792291/
https://ncbi.nlm.nih.gov/pubmed/29079598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.178996
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados